Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BTAI Bioxcel Therapeutics Inc.

休市中 08-16 16:00:00 EDT

0.6732

-0.0068

-1.00%

盘后0.6699

-0.0033-0.49%

19:50 EDT

最高0.7000	最低0.6605	成交量42.99万
今开0.6984	昨收0.6800	日振幅5.81%
总市值2,743万	流通市值1,954万	总股本4,074万
成交额29.27万	换手率1.48%	流通股本2,903万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":0.6732,"timestamp":1723838400000,"preClose":0.68,"halted":0,"volume":429942,"hourTrading":{"tag":"盘后","latestPrice":0.6699,"preClose":0.6732,"latestTime":"19:50 EDT","volume":8024,"amount":5478.2529,"timestamp":1723852244107},"delay":0,"floatShares":29028500,"shares":40743762,"eps":-3.322252,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0068,"latestTime":"08-16 16:00:00 EDT","open":0.6984,"high":0.7,"low":0.6605,"amount":292660.08769314,"amplitude":0.058088,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.322252,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1520485200000,"adjPreClose":0.68,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.71,"preClose":0.68,"latestTime":"08:43 EDT","volume":68,"amount":48.28,"timestamp":1723812215313},"postHourTrading":{"tag":"盘后","latestPrice":0.6699,"preClose":0.6732,"latestTime":"19:50 EDT","volume":8024,"amount":5478.2529,"timestamp":1723852244107},"volumeRatio":0.7533088738927455,"impliedVol":0.1333,"impliedVolPercentile":0.0238},"requestUrl":"/m/hq/s/BTAI","defaultTab":"news","newsList":[{"id":"2459478603","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大涨7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459478603","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459478603?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728643,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅拉升7.32%。截至发稿，该股报0.729美元/股，成交量4766股，换手率0.01%，振幅0.00%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2128.35%、1428.94%、329.34%，振幅较大的相关个股有Celcuity Inc.、Tyra Biosciences, Inc.、Vaxart, Inc. - Common Stock，振幅分别为9.31%、5.10%、5.07%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213043a1d4703d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213043a1d4703d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"gpt_icon":0},{"id":"2459868474","title":"Bioxcel Therapeutics, Inc.盘中异动 快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459868474","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459868474?lang=zh_cn&edition=full","pubTime":"2024-08-15 02:08","pubTimestamp":1723658933,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日02时08分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下跌5.41%。截至发稿，该股报0.657美元/股，成交量22.0228万股，换手率0.54%，振幅9.19%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Unicycive Therapeutics, Inc.、Cormedix Inc.、Notable Labs, Ltd.涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为93.72%、81.18%、70.35%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815020853ab5db1e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815020853ab5db1e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"gpt_icon":0},{"id":"2459890260","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459890260","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459890260?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:15","pubTimestamp":1723558546,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时15分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速拉升5.38%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、冠科美博涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为128.29%、106.12%、24.26%，振幅较大的相关个股有冠科美博、Tempest Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为45.17%、36.57%、33.11%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322154698e34deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322154698e34deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":"    路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价，其中包括 Airbnb、Dollar General 和沃尔玛。要闻             * Airbnb Inc   ：杰富瑞将目标价从 150 美元下调至 125 美元              * Dollar General Corp   ：杰富瑞将目标价从160美元下调至145美元             * Hilton Grand Vacations Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc   ：摩根大通将目标价从45美元下调至10美元              * Pacira Biosciences Inc   ：Piper Sandler将目标价从42美元下调至11美元             * Pacira Biosciences Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051225.USD","ROK","RDFN","HBI","ARDT","HGV","GSHD","HSIC","RDNT","BWIN","LU0211327993.USD","BK4175","BTAI","BJ","CBUS","DLTR","EWTX","LU1069347547.HKD","SWIM","STEP","ZD","BK4173","CCOI","SKY","OKE","DG","IE0034390439.USD","LEGH","EXPE","NNI","GHLD","LU2361045086.USD","OPAD","CC","PCRX","BK4535","LU2361044949.HKD","ITOS","CARG","ABNB","HLMN","FTDR","BURL","GCMG","FMC","PX","NTLA","LU2361044865.SGD","WMT"],"gpt_icon":1},{"id":"2458692026","title":"Bioxcel Therapeutics, Inc.2024财年第二财季实现净利润-8.30百万美元，同比增加84.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692026","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692026?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:14","pubTimestamp":1723392855,"startTime":"0","endTime":"0","summary":"8月12日，Bioxcel Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-8.30百万美元，同比增加84.49%；其中营业收入为1.10百万美元，同比增加140.70%，每股基本收益为-0.21美元。机构评级：截至2024年8月12日，当前有5家机构对Bioxcel Therapeutics, Inc.目标价做出预测，其中目标均价为4.60美元，其中最低目标价为1.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200142595904493&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200142595904493&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2457844947","title":"Bioxcel Therapeutics, Inc.盘中异动 快速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844947?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037514,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅拉升5.21%。截至发稿，该股报1.010美元/股，成交量1.3294万股，换手率0.03%，振幅1.86%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为263.71%、145.07%、42.25%，振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、天境生物，振幅分别为16.93%、13.79%、12.26%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131559f17746c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072131559f17746c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2457773948","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457773948","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457773948?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864771,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Bioxcel Therapeutics, Inc.股票出现异动，股价急速跳水5.06%。截至发稿，该股报0.940美元/股，成交量6.6902万股，换手率0.18%，振幅0.89%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为981.75%、35.48%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Cue Biopharma, Inc.、Compass Therapeutics, Inc.，振幅分别为13.04%、12.33%、12.19%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213251aefd4c0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213251aefd4c0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"gpt_icon":0},{"id":"2456494233","title":"BioXcel Therapeutics Inc   预计每股亏损71美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456494233","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456494233?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:52","pubTimestamp":1722610332,"startTime":"0","endTime":"0","summary":"   * BioXcel Therapeutics Inc    将于8月6日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于康涅狄格州纽黑文的公司预计将实现66.1%的营收增长，从去年同期的45.7万美元增至75.92万美元。* LSEG 分析师对 BioXcel Therapeutics Inc 的平均预期是每股亏损 71 美分。* 华尔街对 BioXcel Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 1.03 美元。8月2日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2452157689","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘大幅下挫6.71%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452157689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452157689?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:37","pubTimestamp":1721223477,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时37分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅下挫6.71%。截至发稿，该股报1.25美元/股，成交量88.1345万股，换手率2.35%，振幅6.71%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为769.55%、572.63%、138.67%，振幅较大的相关个股有Aptevo Therapeutics Inc.、4D Molecular Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.，振幅分别为25.37%、20.47%、19.03%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213757af92c9ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213757af92c9ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2448483480","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448483480","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448483480?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:54","pubTimestamp":1720014842,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时54分，Bioxcel Therapeutics, Inc.股票出现波动，股价急速下挫5.36%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Cns Pharmaceuticals, Inc.、Annovis Bio, Inc.、Seastar Medical Holding Corporation较为活跃，换手率分别为3545.07%、22.80%、5.70%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.，振幅分别为86.67%、61.11%、49.56%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215402af906647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215402af906647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI","BK4139"],"gpt_icon":0},{"id":"2446668861","title":"Bioxcel Therapeutics, Inc.盘中异动 股价大涨6.30%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446668861","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446668861?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:36","pubTimestamp":1719581792,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时36分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅拉升6.30%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。消息层面，截至21时36分，《CCORF维持BioXcel Therapeutics买入评级，维持目标价7美元》资讯为影响Bioxcel Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213633aef728c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213633aef728c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2446581785","title":"加拿大投资银行集团：维持BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价由7.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446581785","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446581785?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:31","pubTimestamp":1719495113,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0},{"id":"2440119236","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440119236","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440119236?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:56","pubTimestamp":1717509379,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时56分，Bioxcel Therapeutics, Inc.股票出现异动，股价急速跳水5.03%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为49.56%、37.53%、28.36%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、31.22%、28.08%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215619941ec44a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215619941ec44a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2436276946","title":"Bioxcel Therapeutics, Inc.2024财年第一财季实现净利润-26.79百万美元，同比增加49.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436276946","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436276946?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:24","pubTimestamp":1715963076,"startTime":"0","endTime":"0","summary":"3月31日，Bioxcel Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-26.79百万美元，同比增加49.26%；其中营业收入为582000.00美元，同比增加182.52%，每股基本收益为-0.87美元。机构评级：截至2024年3月31日，当前有5家机构对Bioxcel Therapeutics, Inc.目标价做出预测，其中目标均价为6.30美元，其中最低目标价为3.50美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800244887750d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800244887750d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2434203018","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大涨6.60%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434203018","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434203018?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:34","pubTimestamp":1715261649,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时34分，Bioxcel Therapeutics, Inc.股票出现异动，股价大幅上涨6.60%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，再鼎医药、Notable Labs, Ltd.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃，换手率分别为38.25%、12.09%、3.81%，振幅较大的相关个股有Notable Labs, Ltd.、180 Life Sciences Corp C/Wts 07/11/2025、Gain Therapeutics, Inc.，振幅分别为22.79%、21.74%、12.04%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921340987e50f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921340987e50f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTAI","LENZ","BK4139"],"gpt_icon":0},{"id":"2433780273","title":"BioXcel Therapeutics Inc   预计每股亏损70美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433780273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433780273?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:59","pubTimestamp":1715101156,"startTime":"0","endTime":"0","summary":"   * BioXcel Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于康涅狄格州纽黑文的公司的营收预计将从一年前的20.6万美元增至46.4万美元，增幅为125.2%。* LSEG 分析师对 BioXcel Therapeutics Inc 的平均预期是每股亏损 70 美分。* 华尔街对 BioXcel Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 2.51 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","LENZ"],"gpt_icon":0},{"id":"2430824522","title":"Bioxcel Therapeutics, Inc.盘中异动 早盘股价大跌5.35%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430824522","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430824522?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:32","pubTimestamp":1714055576,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时32分，Bioxcel Therapeutics, Inc.股票出现波动，股价快速跳水5.35%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.69%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申BioXcel Therapeutics评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522325679237b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522325679237b6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2429119167","title":"Bioxcel Therapeutics, Inc.盘中异动 急速上涨5.26%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429119167?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:56","pubTimestamp":1713884167,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时56分，Bioxcel Therapeutics, Inc.股票出现异动，股价快速拉升5.26%。Bioxcel Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Bioxcel Therapeutics, Inc.公司简介：BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：重申BioXcel Therapeutics评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322560787e82dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042322560787e82dd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTAI","LENZ"],"gpt_icon":0},{"id":"2429670201","title":"HC Wainwright & Co.：重申BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429670201","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429670201?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:36","pubTimestamp":1713868586,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318362887a5c895&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042318362887a5c895&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BTAI"],"gpt_icon":0},{"id":"2429626651","title":"HC Wainwright &amp; Co.：重申BioXcel Therapeutics(BTAI.US)评级，由买入调整至买入评级, 目标价10.","url":"https://stock-news.laohu8.com/highlight/detail?id=2429626651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429626651?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:28","pubTimestamp":1713868110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","BTAI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioxceltherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0792},{"period":"1month","weight":-0.4741},{"period":"3month","weight":-0.6748},{"period":"6month","weight":-0.8082},{"period":"1year","weight":-0.8463},{"period":"ytd","weight":-0.7718}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bioxcel Therapeutics, Inc.于2017年3月29日成为特拉华州公司，为BioXcel的全资附属公司。 BioXcel Therapeutics，Inc.或BTI是一家临床阶段的生物制药公司，专注于药物开发，利用新型人工智能或人工智能识别神经科学和免疫肿瘤学领域的下一波药物。他们的药物再创新方法利用现有批准的药物或经临床验证的产品候选药物以及大数据和专有机器学习算法来确定新的治疗指标。他们的两个最先进的临床开发项目是BXCL501，一种a2a肾上腺素能受体激动剂右美托咪定或Dex的舌下薄膜制剂，用于急性治疗由神经和精神疾病引起的激动，和BXCL701，一种用于治疗罕见形式的前列腺癌和胰腺癌。他们在2017年12月开始使用Dex在轻度可能AD中的IV制剂的1b期药代动力学/药效学或PK / PD安全性研究，并且他们计划在精神分裂症患者中使用Dex的IV制剂开始1b期药代动力学/药效学安全性研究，他们期望在2018年下半年报告这两项研究的数据。他们还打算在2018年开始两项计划的第二阶段概念证明或PoC开放标签临床试验。他们预计，到2018年底，计划在BXCL501计划的阶段2 PoC开放标签临床试验中提供的数据读数将可用。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.129318},{"month":2,"riseRate":0.833333,"avgChangeRate":0.365471},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.136546},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02344},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.13038},{"month":7,"riseRate":0.428571,"avgChangeRate":0.032629},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.174837},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.136967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.013323},{"month":11,"riseRate":0.333333,"avgChangeRate":0.076409},{"month":12,"riseRate":0.5,"avgChangeRate":0.192882}],"exchange":"NASDAQ","name":"Bioxcel Therapeutics Inc.","nameEN":"Bioxcel Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Bioxcel Therapeutics Inc.,BTAI,Bioxcel Therapeutics Inc.股票,Bioxcel Therapeutics Inc.股票老虎,Bioxcel Therapeutics Inc.股票老虎国际,Bioxcel Therapeutics Inc.行情,Bioxcel Therapeutics Inc.股票行情,Bioxcel Therapeutics Inc.股价,Bioxcel Therapeutics Inc.股市,Bioxcel Therapeutics Inc.股票价格,Bioxcel Therapeutics Inc.股票交易,Bioxcel Therapeutics Inc.股票购买,Bioxcel Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bioxcel Therapeutics Inc.(BTAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Bioxcel Therapeutics Inc.(BTAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}